Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy

2012 ◽  
Vol 107 (4) ◽  
pp. 388-392 ◽  
Author(s):  
Hyung Seok Park ◽  
Seho Park ◽  
JungHoon Cho ◽  
Ji Min Park ◽  
Seung Il Kim ◽  
...  
Keyword(s):  
Sentinel Node ◽  
Sentinel Node Biopsy ◽  
Ductal Carcinoma In Situ ◽  
Needle Biopsy ◽  
Carcinoma In Situ ◽  
Ductal Carcinoma ◽  
Node Biopsy ◽  
Risk Predictors

scholarly journals Ductal Carcinoma in situ after Core Needle Biopsy: In Which Cases Is a Sentinel Node Biopsy Necessary?

Breast Care ◽  
2019 ◽  
Vol 15 (3) ◽  
pp. 260-264
Author(s):  
Robbert J.H. van Leeuwen ◽  
Birgitta Kortmann ◽  
Herman Rijna
Keyword(s):  
Sentinel Node ◽  
Sentinel Node Biopsy ◽  
Ductal Carcinoma In Situ ◽  
Core Needle Biopsy ◽  
Needle Biopsy ◽  
Carcinoma In Situ ◽  
Ductal Carcinoma ◽  
Core Needle ◽  
Node Biopsy

Introduction: In some hospitals it is still common practice to carry out a sentinel node biopsy (SNB) if ductal carcinoma in situ (DCIS) is determined in preoperative staging, although this is against international guidelines. The reason for this is because an infiltrative component can be demonstrated frequently in the final pathohistological examination. In this study, we wanted to investigate possible predictors for infiltrative growth, to select patients to do an SNB or to omit it. Material and Methods: All patients with DCIS in the core needle biopsy (CNB), who were treated with surgery including an SNB, were included in a prospective data registry. Patient characteristics were collected through physical examination, mammography and ultrasonography. All characteristics of the DCIS were noted. After surgery, the pathological results were collected. Results: From the 287 patients, 39 (13.6%) had an infiltrative component in the definitive pathological examination despite only DCIS in preoperative CNB. In total, there were only 14 (4.9%) positive SNBs, of which 11 patients had infiltrative growth in the breast tumor and 3 (1.2% of patients with DCIS alone in the final pathology) did not. In addition, characteristics of the CNB, including microcalcifications and comedonecrosis, did not show a statistically significant higher risk for infiltration. Discussion: Considering the low rates of positive SNBs in our population, we think that an SNB should not be performed in advance when DCIS is diagnosed, because if infiltrative growth is found in the final biopsy, an SNB could always be performed afterwards. Only if an SNB cannot be performed afterwards is an SNB indicated.

Sentinel Node Biopsy in Ductal Carcinoma In Situ Patients

2000 ◽  
Vol 7 (1) ◽  
pp. 15-20 ◽  
Author(s):  
Solange Pendas ◽  
Emilia Dauway ◽  
Rosemary Giuliano ◽  
NiNi Ku ◽  
Charles E. Cox ◽  
...  
Keyword(s):  
Sentinel Node ◽  
Sentinel Node Biopsy ◽  
Ductal Carcinoma In Situ ◽  
Carcinoma In Situ ◽  
Ductal Carcinoma ◽  
Node Biopsy

Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review

2007 ◽  
Vol 43 (6) ◽  
pp. 993-1001 ◽  
Author(s):  
C.H.M. van Deurzen ◽  
M.G.G. Hobbelink ◽  
R. van Hillegersberg ◽  
P.J. van Diest
Keyword(s):  
Sentinel Node ◽  
Sentinel Node Biopsy ◽  
Ductal Carcinoma In Situ ◽  
Carcinoma In Situ ◽  
Ductal Carcinoma ◽  
Node Biopsy

Benefit of sentinel node biopsy in patients with breast ductal carcinoma in situ

2009 ◽  
Vol 85 (2) ◽  
pp. 92-95
Author(s):  
Isabel T. Rubio ◽  
Isabel Roca ◽  
Dolors Sabadell ◽  
Jordi Xercavins
Keyword(s):  
Sentinel Node ◽  
Sentinel Node Biopsy ◽  
Ductal Carcinoma In Situ ◽  
Carcinoma In Situ ◽  
Ductal Carcinoma ◽  
Node Biopsy
Sign in / Sign up

Export Citation Format

Share Document